Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Pagibaximab

EU orphan designation number: EU/3/10/743
Active ingredient: Pagibaximab
Indication: Prevention of sepsis caused by Gram positive pathogens in premature infants less than or equal to 34 weeks of gestational age
Sponsor: Theorem Clinical Research GmbH
Königsteiner Strasse 10, D-65812 Bad Soden a. Ts., Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2010 Centralised Orphan - Designation EMEA/OD/156/09 (2010)3862 of 09/06/2010
24/08/2011 Other procedure EMEA/OD/156/09